HAMILTON LANE ADVISORS LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 166 filers reported holding CARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
HAMILTON LANE ADVISORS LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$79
-54.3%
16,1240.0%0.03%
-57.1%
Q4 2022$173
-99.9%
16,1240.0%0.06%
+14.5%
Q3 2022$151,000
+2.7%
16,1240.0%0.06%
-3.5%
Q2 2022$147,000
-25.0%
16,1240.0%0.06%
+29.5%
Q1 2022$196,0000.0%16,1240.0%0.04%
+76.0%
Q4 2021$196,000
-21.3%
16,1240.0%0.02%
-40.5%
Q3 2021$249,000
+8.3%
16,1240.0%0.04%
-41.7%
Q2 2021$230,000
-61.7%
16,124
-73.0%
0.07%
-73.7%
Q1 2015$600,000
-24.5%
59,713
-25.1%
0.27%
-9.3%
Q4 2014$795,000
+5.6%
79,713
-11.1%
0.30%
+23.3%
Q3 2014$753,00089,7130.24%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders